| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/2008 | US7335479 Assays for sensory modulators using a sensory cell specific G-protein alpha subunit |
| 02/26/2008 | US7335477 Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines |
| 02/26/2008 | US7335475 nucleotide sequences coding tumor suppressor (PR/SET) polypeptides for diagnosis, prognosis and treatment of cell proliferative disorders; anticarcinogenic agents; tumor suppressor genes |
| 02/26/2008 | US7335473 Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits |
| 02/26/2008 | US7335468 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 02/26/2008 | US7335370 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/26/2008 | US7335369 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/26/2008 | US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus |
| 02/26/2008 | US7335366 Attenuated bovine respiratory syncytial virus |
| 02/26/2008 | US7335365 HIV-encoded chemoattractant |
| 02/26/2008 | US7335364 Modified Vaccinia Ankara virus variant |
| 02/26/2008 | US7335361 Fusion antigen used as vaccine |
| 02/26/2008 | US7335360 Method and device for detecting feline immunodeficiency virus |
| 02/26/2008 | US7335359 Glycosylated specificity exchangers |
| 02/26/2008 | US7335358 Methods of treating psoriasis with anti-TNF antibodies |
| 02/26/2008 | US7335357 Antagonists of neuropilin receptor function and use thereof |
| 02/26/2008 | US7335353 Porcine cells comprising an adenovirus E3 gene region |
| 02/26/2008 | US7335351 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 02/26/2008 | US7335350 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide; preventing autoimmune and inflammatory diseases and bacterial and viral infections |
| 02/26/2008 | CA2369590C Sodium/proton antiporter gene |
| 02/26/2008 | CA2353788C Human cervical cancer 1 protooncogene and protein encoded therein |
| 02/26/2008 | CA2351722C Mast cell-specific signal transducer and cdna thereof |
| 02/26/2008 | CA2315241C Protein rim2 |
| 02/26/2008 | CA2138931C Method for determining platelet aggregation |
| 02/26/2008 | CA2078544C Method and compositions for treating injury |
| 02/21/2008 | WO2008022302A2 Immunogenic pcpa polypeptides and uses thereof |
| 02/21/2008 | WO2008022151A1 Prophylactic treatment of hemophilia |
| 02/21/2008 | WO2008021974A1 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase |
| 02/21/2008 | WO2008021872A1 Diuretic and natriuretic polypeptides |
| 02/21/2008 | WO2008021725A2 Chemical compounds |
| 02/21/2008 | WO2008021560A2 Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| 02/21/2008 | WO2008021412A2 Interferon beta and transferrin fusion proteins |
| 02/21/2008 | WO2008021379A2 Increased activity and efficiency of expansin-like proteins |
| 02/21/2008 | WO2008021160A2 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 02/21/2008 | WO2008021140A2 Recombinant aav production in mammalian cells |
| 02/21/2008 | WO2008020968A2 Recombinant interferon-beta with enhanced biological activity |
| 02/21/2008 | WO2008020596A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | WO2008020331A2 Polynucleotides allowing the expression and secretion of recombinant hepatitis b surface antigen (hbsag) virus-like particles containing a foreign peptide, their production and use |
| 02/21/2008 | WO2008020293A2 West nile virus envelope (e) protein antigen and immunoassay |
| 02/21/2008 | WO2008020131A1 Method of screening for compounds with anti-amyloid properties |
| 02/21/2008 | WO2008020108A1 Peptides which are immunogenic in relation to the genuses listeria and mycobacterium, antibodies and uses of these |
| 02/21/2008 | WO2008020075A1 Transglutaminase variants with improved specificity |
| 02/21/2008 | WO2008020074A1 Transglutaminase variants with improved specificity |
| 02/21/2008 | WO2008019735A1 Determination of renin/prorenin receptor activity |
| 02/21/2008 | WO2008019491A1 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein |
| 02/21/2008 | WO2008019486A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | WO2008003327A3 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/21/2008 | WO2008000881B1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 02/21/2008 | WO2007139914A3 Collagen mimics |
| 02/21/2008 | WO2007126887A3 Immunogenic compositions comprising polynucleotides encoding matrix protein 2 and methods of use |
| 02/21/2008 | WO2007123791A3 Methods of determining cellular chemosensitivity |
| 02/21/2008 | WO2007121364A3 Tetramerizing polypeptides and methods of use |
| 02/21/2008 | WO2007120463A3 Compositions and methods for modulation of nek2 kinase activity |
| 02/21/2008 | WO2007102812A9 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells |
| 02/21/2008 | WO2007102354A3 Gene encoding protein responsible for storage resistance of yeast and use thereof |
| 02/21/2008 | WO2007086882A3 Biological polymer with differently charged portions |
| 02/21/2008 | WO2007084388A3 Nogo-b receptor |
| 02/21/2008 | WO2006136084A8 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 02/21/2008 | WO2006053439A9 Hcv f protein and uses thereof |
| 02/21/2008 | WO2006044334A3 Platelet-derived growth factor compositions and methods of use thereof |
| 02/21/2008 | WO2005089445A3 Follicle stimulating hormone superagonists |
| 02/21/2008 | WO2005020898A3 Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 02/21/2008 | WO2005016247A3 Dna sequences, peptides, antibodies and vaccines for prevention and treatment of sars |
| 02/21/2008 | WO2004104550A3 Rapid and specific detection of enterobacter sakazakii |
| 02/21/2008 | US20080047034 Nucleic acid molecules encoding novel bacillus thuringiensis Cry2Ae insecticidal proteins, plant cells, plant or seeds comprising the nucleic acid molecules and methods of using same |
| 02/21/2008 | US20080047030 Plant Dwarfing Gene |
| 02/21/2008 | US20080047029 Flowering Induction |
| 02/21/2008 | US20080047026 by obtaining a population of cells from a sample and sorting the population of cells based on the presence of CD34 and the amount of a selected slow-cycling cell marker expressed by each cell, |
| 02/21/2008 | US20080045926 Treatment of Conditions Involving Dopaminergic Neuronal Degeneration Using Nogo Receptor Antagonists |
| 02/21/2008 | US20080045701 Human Monoclonal Antibody Having Fat-Reducing Effect |
| 02/21/2008 | US20080045700 Canine CD20 Compositions |
| 02/21/2008 | US20080045699 Interleukin-1 Related Gene and Protein |
| 02/21/2008 | US20080045698 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080045697 crystal structure of the macrophage specific receptor; Complement Receptor of the Immunoglobulin superfamily (CRIG) or STIgMA; for drug screening |
| 02/21/2008 | US20080045696 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus |
| 02/21/2008 | US20080045695 Fusion Protein Suitable to be Expressed High Effectively and the Production Method thereof |
| 02/21/2008 | US20080045694 Preparation of Solid Phase Bound Peptides or Pnas |
| 02/21/2008 | US20080045693 Novel flea saliva protein |
| 02/21/2008 | US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa |
| 02/21/2008 | US20080045589 Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer |
| 02/21/2008 | US20080045499 Preferential Inhibition of Presenilin-1 |
| 02/21/2008 | US20080045459 Orally administered peptides synergize statin activity |
| 02/21/2008 | US20080045458 synthetic polypeptides; isolated and purified from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake; encoded from nucleic acid; analgesic or insecticide |
| 02/21/2008 | US20080045457 Ancestral Hepatitis C virus envelope protein sequence |
| 02/21/2008 | US20080045456 Use of wild type angiogenin |
| 02/21/2008 | US20080045455 RAGE fusion proteins, formulations, and methods of use thereof |
| 02/21/2008 | US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same |
| 02/21/2008 | US20080045453 Method of producing biologically active vitamin K dependent proteins by recombinant methods |
| 02/21/2008 | US20080045452 Regulation of Cytokine Synthesis and Release |
| 02/21/2008 | US20080045450 GLP-2 Derivatives |
| 02/21/2008 | US20080044907 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 02/21/2008 | US20080044878 Novel Promoters |
| 02/21/2008 | US20080044867 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044858 Using trangenic fungus to produce heterologous proteins; culturing |
| 02/21/2008 | US20080044856 Thermostable proteins and methods of making and using thereof |
| 02/21/2008 | US20080044838 Molecular Spacer Arm, Process for the Production Thereof and Uses on an Analytical Chip Comprising Molecules or Biomolecules |
| 02/21/2008 | US20080044837 antibody that binds to the extracellular portion of the human Programmed Death-1 (PD-1) receptor at a membrane proximal region; identifying a modulator of CD28 |
| 02/21/2008 | US20080044835 Mammalian chemokine reagents |
| 02/21/2008 | US20080044828 CUDR as biomarker for cancer progression and therapeutic response |